Medicines production

15.06.2016, 16:05
Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that its Board of Directors has appointed Thomas W. Ross, Sr. as its lead independent director. Mr. Ross, who has been a member of Valeant's Board since March 8, 2016, serves on the Board's Nominating and Corporate Governance Committee and is Chairperson of its Conduct and Compliance Committee.

Комментарии

Для добавления комментария необходимо войти под своей учётной записью или зарегистрироваться.
Комментариев нет

All news in one column

Самое обсуждаемое

News archive for the month

ноябрь, 2024
motuwethfrsasu
28293031123
45678910
11121314151617
18192021222324
2526272829301